3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell PotencyIan M. Bell, C. Blair Zartman, Kelly Hamilton et al.|Journal of Medicinal Chemistry|2002Cited by 86
Design and Biological Activity of (<i>S</i>)-4-(5-{[1-(3-Chlorobenzyl)-2- oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-Aminopyrrolidinone Farnesyltransferase Inhibitor with Excellent Cell PotencyIan M. Bell, Theresa M. Williams, Steven N. Gallicchio et al.|Journal of Medicinal Chemistry|2001Cited by 43
Farnesyltransferase inhibitors and anti-Ras therapyW. Wayt Gibbs, Allen Oliff, Nancy E. Kohl et al.|Breast Cancer Research and Treatment|1996Cited by 42
High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123Carolyn A. Buser, Kenneth S. Koblan, Christopher J. Dinsmore et al.|Analytical Biochemistry|2001Cited by 30
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-IDiem N. Nguyen, Carolyn A. Buser, Craig A. Stump et al.|Bioorganic & Medicinal Chemistry Letters|2002Cited by 22